Javascript must be enabled to continue!
Polymyalgia Rheumatica - a Disease of the Elderly
View through CrossRef
Polymyalgia rheumatica is a disease that occurs mostly in the elderly and is rarely seen in patients less than 50 years of age. Polymyalgia rheumatica is a vasculitis, which manifests itself as an inflammatory disease of the vascular wall that can affect any type of blood vessel, regardless of its size. It has been considered a form of giant cell arteritis, involving primarily large and medium arteries and to a lesser extent the arterioles. Clinical manifestations are caused by the generic pathogenic process and depend on the characteristics of the damaged organ. PMR is a senescence-related immune disorder. It has been defined as a stand-alone condition and a syndrome referred to as rheumatic polyarteritis with manifestations of giant cell arteritis (especially in cases of Horton�s disease and temporal arteritis) which are commonly associated with polymyalgia. The clinical presentation is clearly dominated by the painful girdle syndrome, with a feeling of general discomfort. Polymyalgia and temporal arteritis may coexist or be consecutive to each other in the same patient, as in most of our patients. The present study describes 3 cases of polymyalgia rheumatica, admitted to the Clinic of Rheumatology of Sf. Apostol Andrei Hospital, Galati. The cases were compared with the literature. Two clinical aspects (polymyalgia rheumatica and/or Horton�s disease) and the relationship between them were also considered. Polymyalgia rheumatica is currently thought to have a multifactorial etiology, in which the following factors play a role: genetic factors or hereditary predisposition (some individuals are more prone to this disease), immune factors and viral infections (triggers of the disease). Other risk factors of polymyalgia rheumatica include age over 50 years and the association with giant cell arteritis. The characteristic feature of the disease is girdle pain, with intense stiffness of at least one hour�s duration. Markers of inflammation, erythrocyte sedimentation rate and C-reactive protein are almost always increased at the onset of the disease. Diseases that can mimic the clinical picture of polymyalgia rheumatica are neoplasia, infections, metabolic disorders of the bone and endocrine diseases.
Revista de Chimie SRL
Title: Polymyalgia Rheumatica - a Disease of the Elderly
Description:
Polymyalgia rheumatica is a disease that occurs mostly in the elderly and is rarely seen in patients less than 50 years of age.
Polymyalgia rheumatica is a vasculitis, which manifests itself as an inflammatory disease of the vascular wall that can affect any type of blood vessel, regardless of its size.
It has been considered a form of giant cell arteritis, involving primarily large and medium arteries and to a lesser extent the arterioles.
Clinical manifestations are caused by the generic pathogenic process and depend on the characteristics of the damaged organ.
PMR is a senescence-related immune disorder.
It has been defined as a stand-alone condition and a syndrome referred to as rheumatic polyarteritis with manifestations of giant cell arteritis (especially in cases of Horton�s disease and temporal arteritis) which are commonly associated with polymyalgia.
The clinical presentation is clearly dominated by the painful girdle syndrome, with a feeling of general discomfort.
Polymyalgia and temporal arteritis may coexist or be consecutive to each other in the same patient, as in most of our patients.
The present study describes 3 cases of polymyalgia rheumatica, admitted to the Clinic of Rheumatology of Sf.
Apostol Andrei Hospital, Galati.
The cases were compared with the literature.
Two clinical aspects (polymyalgia rheumatica and/or Horton�s disease) and the relationship between them were also considered.
Polymyalgia rheumatica is currently thought to have a multifactorial etiology, in which the following factors play a role: genetic factors or hereditary predisposition (some individuals are more prone to this disease), immune factors and viral infections (triggers of the disease).
Other risk factors of polymyalgia rheumatica include age over 50 years and the association with giant cell arteritis.
The characteristic feature of the disease is girdle pain, with intense stiffness of at least one hour�s duration.
Markers of inflammation, erythrocyte sedimentation rate and C-reactive protein are almost always increased at the onset of the disease.
Diseases that can mimic the clinical picture of polymyalgia rheumatica are neoplasia, infections, metabolic disorders of the bone and endocrine diseases.
Related Results
Polymyalgia rheumatica: 125 years of progress?
Polymyalgia rheumatica: 125 years of progress?
Objectives
On the 125th anniversary of the first recognised publication on polymyalgia rheumatica, a review of the literature was undertaken to assess what prog...
Polymyalgia rheumatica: Stellenwert des Routineultraschalls in der Primärversorgung
Polymyalgia rheumatica: Stellenwert des Routineultraschalls in der Primärversorgung
Vascular ultrasound can be useful in the diagnostic investigation of patients with suspected giant cell arteritis. The clinical overlap between polymyalgia rheumatica and giant cel...
35. A referred case of probable PMR with a different outcome
35. A referred case of probable PMR with a different outcome
Abstract
Introduction
This is the case of a 67-year-old woman who presented to the rheumatology clinic with suspected diagnosis ...
A case report of polymyalgia rheumatica
A case report of polymyalgia rheumatica
The presented case report concerns a 62-year-old male patient who was admitted to the rheumatology department with a fever, shoulder and hip joint pain, significant limitation of m...
Mizoribine is as Effective as Methotrexate for the Treatment of Polymyalgia Rheumatica: A Retrospective Case Series Analysis
Mizoribine is as Effective as Methotrexate for the Treatment of Polymyalgia Rheumatica: A Retrospective Case Series Analysis
Objectives: This study aims to evaluate the efficacy and safety of mizoribine (MZR) as a steroid-sparing agent compared to methotrexate (MTX) in the treatment of polymyalgia rheuma...
Clinical Features, Treatment and Monitoring in Patients With Polymyalgia Rheumatica
Clinical Features, Treatment and Monitoring in Patients With Polymyalgia Rheumatica
Objectives: This study aims to evaluate the clinical symptoms and laboratory findings of Turkish patients with polymyalgia rheumatica.
Patients and methods: Clinical data of 41 pa...
PENGARUH KUALITAS HIDUP LANSIA TERHADAP RISIKO ELDERLY ABUSE: SYSTEMATIC REVIEW AND META ANALYSIS
PENGARUH KUALITAS HIDUP LANSIA TERHADAP RISIKO ELDERLY ABUSE: SYSTEMATIC REVIEW AND META ANALYSIS
Latar belakang: Negara Indonesia saat ini mulai memasuki periode aging population. Diproyeksikan tahun 2035 mencapai 48,2 juta jiwa 15,77%, lebih tinggi dari angka global pada angk...
Assessing quality of life of the elderly people in Khon Kaen Province
Assessing quality of life of the elderly people in Khon Kaen Province
This thesis deals with the concept of quality of life of elderly people. This thesis portfolio consists of: (1) an essay on what is quality of life in elderly people and how it cou...

